Unauthorized Disclosure or Use. During Executive’s employment with the Company, Executive shall use and disclose the Company’s Confidential Information solely in the interests of the Company and its Affiliates. For a period of two (2) years following the Termination Date, Executive shall not, without the written consent of the Company’s Board of Directors, directly or indirectly use or disclose to any person or entity, any Confidential Information, except to the extent required by law or legal process. Notwithstanding anything to the contrary in this Agreement, Executive’s obligations under this Section 7(a) with respect to Confidential Information (i) that constitutes a trade secret under applicable law shall continue until the longer of (1) such two-year period; or (2) when such Confidential Information is no longer a trade secret through no action or inaction by Executive and (ii) that is subject to contractual restrictions between the Company and third parties (not including Affiliates) or judicial order shall continue until the longer of (1) such two year period; or (2) when such contractual or judicial restriction expires.
Unauthorized Disclosure or Use. Employee will promptly advise the Company of any unauthorized disclosure or use, or suspected unauthorized disclosure or use, of the Confidential Information by Employee or any other person or entity that is known to Employee.
Unauthorized Disclosure or Use. 5.1. Each party agrees to advise the other party promptly in writing of any unauthorized misappropriation, disclosure or use by any person of the other party’s Confidential Information which may come to its attention and to take all steps reasonably requested by the disclosing party to limit, stop or otherwise remedy such misappropriation, disclosure or use.
Unauthorized Disclosure or Use. While the Executive is employed with the Company and thereafter, the Executive agrees not to (i) use any Confidential Information for any purpose, (ii) disclose any Confidential Information to any person or entity, (iii) keep or make copies of any documents, records or property of any nature whatsoever containing or reflecting any Confidential Information or (iv) assist any third party in engaging in any of the foregoing, except to the extent reasonably necessary or appropriate in connection with the performance of the Executive’s employment duties and responsibilities or expressly authorized by the Board of Directors of the Company. Nothing in this Agreement reduces the Executive’s obligation to comply with applicable laws relating to trade secrets, confidential information and unfair competition. Accordingly, notwithstanding the foregoing, the Executive’s obligations under this Section 5(c) with respect to Confidential Information that constitutes a trade secret under applicable law shall continue until such Confidential Information no longer constitutes a trade secret.
Unauthorized Disclosure or Use. The receiving party acknowledges that all Confidential Information is solely owned by the disclosing party and that the unauthorized disclosure or use of such Confidential Information would cause irreparable harm and significant injury, the degree of which may be difficult to ascertain. Accordingly, the receiving party agrees that the disclosing party will have the right to obtain an immediate injunction enjoining any breach of this Section, as well as a right to pursue any and all other rights and remedies available at law or equity for such a breach.
Unauthorized Disclosure or Use. Glaxo Wellcome shall notify Deltagen immediately in the event of any actual or suspected unauthorized disclosure or use, loss, or theft of the DeltaBase or any part thereof, and shall take all steps reasonably requested by Deltagen to investigate and terminate any of the foregoing. Notwithstanding this obligation, subject to the terms and conditions of this Agreement, Deltagen confirms that during the Access Term, Glaxo Wellcome shall have the right to use the DeltaBase solely for Glaxo Wellcome's internal use by authorized personnel of Glaxo Wellcome at the Installation Site in secure work facilities in accordance with the terms and conditions of this Agreement and the DeltaBase Access Plan set out in Exhibit A. Glaxo Wellcome shall have no access to or right to use the DeltaBase except at the Installation Site under the terms and conditions of this Agreement.
Unauthorized Disclosure or Use. Lexicon shall notify Deltagen immediately in the event of any actual or suspected unauthorized access to, or disclosure, use, loss, or theft of, the DeltaBase or any part thereof, and shall take all steps reasonably Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. requested by Deltagen to investigate and terminate any of the foregoing. Notwithstanding this obligation, subject to the terms and conditions of this Agreement, Deltagen confirms that Lexicon shall have the right to use the DeltaBase solely for Lexicon's internal use by authorized personnel of Lexicon in secure work facilities in accordance with the terms and conditions of this Agreement and the DeltaBase Access Plan set out in Exhibit A. Lexicon shall have no access to or right to use the DeltaBase except under the terms and conditions of this Agreement.
Unauthorized Disclosure or Use. While Executive is employed with the Company and at all times thereafter, Executive shall not (i) use any Confidential Information for any purpose, (ii) disclose any Confidential Information to any person or entity, (iii) keep or make copies of any documents, records or property of any nature containing or reflecting any Confidential Information or (iv) assist any third party in engaging in any of the foregoing, except to the extent reasonably necessary or appropriate in connection with the performance of Executive’s duties and responsibilities as an employee of the Company or expressly authorized by the Board.
Unauthorized Disclosure or Use. Glaxo Wellcome shall notify Deltagen immediately in the event of any actual or suspected unauthorized disclosure or use, loss, or theft of the DeltaBase or any part thereof, and shall take all steps reasonably requested by Deltagen to investigate and terminate any of the foregoing. Notwithstanding this obligation, subject to the [*] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. terms and conditions of this Agreement, Deltagen confirms that during the Access Term, Glaxo Wellcome shall have the right to use the DeltaBase solely for Glaxo Wellcome's internal use by authorized personnel of Glaxo Wellcome at the Installation Site in secure work facilities in accordance with the terms and conditions of this Agreement and the DeltaBase Access Plan set out in Exhibit A. Glaxo Wellcome shall have no access to or right to use the DeltaBase except at the Installation Site under the terms and conditions of this Agreement.
Unauthorized Disclosure or Use. During Executive’s employment, the Company will make Confidential Information available to Executive. While Executive is employed with the Company and at all times after the last day of Executive’s employment with the Company (regardless of the reason that Executive’s employment ceases), Executive will not disclose any Confidential Information to any third party, or use any Confidential Information for Executive’s benefit or the benefit of any third party, unless: (i) Executive first secures the written consent of the Chief Executive Officer of the Company; (ii) the disclosure or use is required for Executive to perform Executive’s employment duties on behalf of the Company; or (iii) the disclosure is otherwise authorized as set forth herein. Executive acknowledges that nothing in this Agreement reduces Executive’s concurrent obligation to comply with applicable laws relating to trade secrets, confidential information, and unfair competition.
